Literature DB >> 23376824

Glutathione oxidation unmasks proarrhythmic vulnerability of chronically hyperglycemic guinea pigs.

Chaoqin Xie1, Nora Biary, Carlo G Tocchetti, Miguel A Aon, Nazareno Paolocci, Justin Kauffman, Fadi G Akar.   

Abstract

Chronic hyperglycemia in type-1 diabetes mellitus is associated with oxidative stress (OS) and sudden death. Mechanistic links remain unclear. We investigated changes in electrophysiological (EP) properties in a model of chronic hyperglycemia before and after challenge with OS by GSH oxidation and tested reversibility of EP remodeling by insulin. Guinea pigs survived for 1 mo following streptozotocin (STZ) or saline (sham) injection. A treatment group received daily insulin for 2 wk to reverse STZ-induced hyperglycemia (STZ + Ins). EP properties were measured using high-resolution optical action potential mapping before and after challenge of hearts with diamide. Despite elevation of glucose levels in STZ compared with sham-operated (P = 0.004) and STZ + Ins (P = 0.002) animals, average action potential duration (APD) and arrhythmia propensity were not altered at baseline. Diamide promoted early (<10 min) formation of arrhythmic triggers reflected by a higher arrhythmia scoring index in STZ (P = 0.045) and STZ + Ins (P = 0.033) hearts compared with sham-operated hearts. APD heterogeneity underwent a more pronounced increase in response to diamide in STZ and STZ + Ins hearts compared with sham-operated hearts. Within 30 min, diamide resulted in spontaneous incidence of ventricular tachycardia and ventricular fibrillation (VT/VF) in 3/6, 2/5, 1/5, and 0/4 STZ, STZ + Ins, sham-operated, and normal hearts, respectively. Hearts prone to VT/VF exhibited greater APD heterogeneity (P = 0.010) compared with their VT/VF-free counterparts. Finally, altered EP properties in STZ were not rescued by insulin. In conclusion, GSH oxidation enhances APD heterogeneity and increases arrhythmia scoring index in a guinea pig model of chronic hyperglycemia. Despite normalization of glycemic levels by insulin, these proarrhythmic properties are not reversed, suggesting the importance of targeting antioxidant defenses for arrhythmia suppression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376824      PMCID: PMC3625895          DOI: 10.1152/ajpheart.00026.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  48 in total

1.  Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome.

Authors:  Fadi G Akar; Gan-Xin Yan; Charles Antzelevitch; David S Rosenbaum
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

2.  Up-regulation of K(+) channels in diabetic rat ventricular myocytes by insulin and glutathione.

Authors:  Zhi Xu; Kaushik P Patel; Marjorie F Lou; George J Rozanski
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

3.  Effects of streptozotocin in the male guinea pig: a potential animal model for studying diabetes.

Authors:  M J Schlosser; J C Kapeghian; A J Verlangieri
Journal:  Life Sci       Date:  1984-08-06       Impact factor: 5.037

4.  Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts.

Authors:  Martin K Slodzinski; Miguel A Aon; Brian O'Rourke
Journal:  J Mol Cell Cardiol       Date:  2008-08-07       Impact factor: 5.000

5.  Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle.

Authors:  F C Howarth; N J Chandler; S Kharche; J O Tellez; I D Greener; T T Yamanushi; R Billeter; M R Boyett; H Zhang; H Dobrzynski
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

6.  Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy.

Authors:  Fadi G Akar; David D Spragg; Richard S Tunin; David A Kass; Gordon F Tomaselli
Journal:  Circ Res       Date:  2004-09-02       Impact factor: 17.367

7.  Altered connexin43 expression produces arrhythmia substrate in heart failure.

Authors:  Steven Poelzing; David S Rosenbaum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06-17       Impact factor: 4.733

8.  Cardiac repolarization during hypoglycaemia in type 1 diabetes: impact of basal renin-angiotensin system activity.

Authors:  Rikke Due-Andersen; Thomas Høi-Hansen; Charlotte Ellen Larroude; Niels Vidiendal Olsen; Jørgen Kim Kanters; Frans Boomsma; Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Europace       Date:  2008-06-04       Impact factor: 5.214

9.  Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children.

Authors:  Nathan Kuppermann; Jeanny Park; Kathryn Glatter; James P Marcin; Nicole S Glaser
Journal:  Arch Pediatr Adolesc Med       Date:  2008-06

10.  Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats.

Authors:  Laura Raimondi; Petra De Paoli; Edoardo Mannucci; Giuseppe Lonardo; Laura Sartiani; Grazia Banchelli; Renato Pirisino; Alessandro Mugelli; Elisabetta Cerbai
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

View more
  10 in total

1.  Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes.

Authors:  Carlo G Tocchetti; Brian A Stanley; Vidhya Sivakumaran; Djahida Bedja; Brian O'Rourke; Nazareno Paolocci; Sonia Cortassa; Miguel A Aon
Journal:  Clin Sci (Lond)       Date:  2015-06-11       Impact factor: 6.124

2.  Reduced Na⁺ current density underlies impaired propagation in the diabetic rabbit ventricle.

Authors:  Catherine L Stables; Hassan Musa; Aditi Mitra; Sandesh Bhushal; Makarand Deo; Guadalupe Guerrero-Serna; Sergey Mironov; Manuel Zarzoso; Karen L Vikstrom; William Cawthorn; Sandeep V Pandit
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

3.  The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.

Authors:  Chaoqin Xie; Jun Hu; Lukas J Motloch; Basil S Karam; Fadi G Akar
Journal:  J Am Coll Cardiol       Date:  2015-09-08       Impact factor: 24.094

4.  Mitochondrial respiration and ROS emission during β-oxidation in the heart: An experimental-computational study.

Authors:  Sonia Cortassa; Steven J Sollott; Miguel A Aon
Journal:  PLoS Comput Biol       Date:  2017-06-09       Impact factor: 4.475

5.  A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment.

Authors:  Brendan K Podell; David F Ackart; Michael A Richardson; James E DiLisio; Bruce Pulford; Randall J Basaraba
Journal:  Dis Model Mech       Date:  2017-01-12       Impact factor: 5.758

Review 6.  Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity.

Authors:  Shanna Hamilton; Dmitry Terentyev
Journal:  Front Physiol       Date:  2018-10-30       Impact factor: 4.566

Review 7.  Mitochondrial Dysfunction-Associated Arrhythmogenic Substrates in Diabetes Mellitus.

Authors:  Jiajia Song; Ruilin Yang; Jing Yang; Lufang Zhou
Journal:  Front Physiol       Date:  2018-12-06       Impact factor: 4.566

8.  Functional crosstalk between the mitochondrial PTP and KATP channels determine arrhythmic vulnerability to oxidative stress.

Authors:  Chaoqin Xie; Justin Kauffman; Fadi G Akar
Journal:  Front Physiol       Date:  2014-07-16       Impact factor: 4.566

Review 9.  The mitochondrial translocator protein and arrhythmogenesis in ischemic heart disease.

Authors:  Lukas J Motloch; Jun Hu; Fadi G Akar
Journal:  Oxid Med Cell Longev       Date:  2015-03-30       Impact factor: 6.543

10.  Diabetes Increases the Vulnerability of the Cardiac Mitochondrial Network to Criticality.

Authors:  Larissa Vetter; Sonia Cortassa; Brian O'Rourke; Antonis A Armoundas; Djahida Bedja; Johann M E Jende; Martin Bendszus; Nazareno Paolocci; Steven J Sollot; Miguel A Aon; Felix T Kurz
Journal:  Front Physiol       Date:  2020-03-10       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.